Medivir is a research-based pharmaceutical company that focuses on developing medicines for cancer. Medivir AB was founded in 1988. Medivir AB's headquarters is located in Stockholm, Stockholms län, SE 111 48.
Medivir AB's CEO, Christine Lind, curren... Medivir AB's CEO, Christine Lind, currently has an approval
rating of 68%. Medivir AB's primary competitors are Moberg Pharma, Trimb & Navamedic.
There have been no acquisitions found related to Medivir AB
Funding data cannot be found related to Medivir AB
Recent investment data cannot be found related to Medivir AB